Corrigendum to “Cobalamin deficiency-induced down-regulation of p75-immunoreactive cell levels in rat central nervous system” [Brain Res. 1157 (2007) 92–99]
详细信息 查看全文
- 作者：Elena Mutti ; Daniela Veber ; Barbara Stampachiacchiere ; Viviana Triaca ; Elena Gammella ; Lorenza Tacchini ; Luigi Aloe ; Giuseppe Scalabrino
- 关键词：Ganoderma lucidum ; Synaptotoxicity ; β ; -amyloid ; Synaptophysin ; Alzheimer's disease
- 刊名：Brain Research
- 出版年：2008
- 出版时间：23 January 2008
- 年：2008
- 卷：1190
- 期：Complete
- 页码：225
- 全文大小：115 K
文摘
Ganoderma lucidum (Leyss. ex Fr.) Karst. (Lingzhi) is a medicinal fungus used clinically in many Asian countries to promote health and longevity. Synaptic degeneration is another key mode of neurodegeneration in Alzheimer's disease (AD). Recent studies have shown the loss of synaptic density proteins in each individual neuron during the progression of AD. It was recently reported that β-amyloid (Aβ) could cause synaptic dysfunction and contribute to AD pathology. In this study, we reported that aqueous extract of G. lucidum significantly attenuated Aβ-induced synaptotoxicity by preserving the synaptic density protein, synaptophysin. In addition, G. lucidum aqueous extract antagonized Aβ-triggered DEVD cleavage activities in a dose-dependent manner. Further studies elucidated that phosphorylation of c-Jun N-terminal kinase, c-Jun, and p38 MAP kinase was attenuated by G. lucidum in Aβ-stressed neurons. Taken together, the results prove a hypothesis that anti-aging G. lucidum can prevent harmful effects of the exterminating toxin Aβ in AD.